Breast cancer can be classified into major molecular subtypes according to the expression of estrogen receptor (ER), progesterone receptor (PR), and over-expression and/or amplification of the human epidermal growth factor 2 (HER2) [3–5]. This evidence concerns the gene PGR and breast carcinoma.